FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2043935090> ?p ?o ?g. }

• W2043935090 endingPage "134" @default.
• W2043935090 startingPage "131" @default.
• W2043935090 abstract "Children born prematurely frequently have recurrent respiratory symptoms at follow-up and benefit frombronchodilator therapy. We have assessed if regular inhaled sodium cromoglycate would reduce this respiratory morbidity and need for bronchodilator therapy. Sixteen symptomatic children (median gestational age 29 weeks, post-natal age 15 months) were entered into a randomized double-blind, placebo-controlled trial. In two 3-week periods, the patients received either placebo or sodium cromoglycate (5 mg) as one puff q.d.s. from an inhaler via a coffee cup. Parents recorded their child's symptoms and need for bronchodilator therapy throughout and lung function was assessed by measurement of functional residual capacity (FRC) at the beginning and end of each 3-week period. The symptom score was reduced by 49% in the active compared to the placebo period (P < 0.01) and bronchodilator was taken on a mean of 2.9 days per infant in the active period compared to 7.9 days in the placebo period (P < 0.01). There was a significant improvement in FRC in ten of 16 patients over the active period but only in two infants over the placebo period (P<0.01). We conclude regular inhaled sodium cromoglycate is useful prophylaxis for symptomatic pre-term children. Children born prematurely frequently have recurrent respiratory symptoms at follow-up and benefit frombronchodilator therapy. We have assessed if regular inhaled sodium cromoglycate would reduce this respiratory morbidity and need for bronchodilator therapy. Sixteen symptomatic children (median gestational age 29 weeks, post-natal age 15 months) were entered into a randomized double-blind, placebo-controlled trial. In two 3-week periods, the patients received either placebo or sodium cromoglycate (5 mg) as one puff q.d.s. from an inhaler via a coffee cup. Parents recorded their child's symptoms and need for bronchodilator therapy throughout and lung function was assessed by measurement of functional residual capacity (FRC) at the beginning and end of each 3-week period. The symptom score was reduced by 49% in the active compared to the placebo period (P < 0.01) and bronchodilator was taken on a mean of 2.9 days per infant in the active period compared to 7.9 days in the placebo period (P < 0.01). There was a significant improvement in FRC in ten of 16 patients over the active period but only in two infants over the placebo period (P<0.01). We conclude regular inhaled sodium cromoglycate is useful prophylaxis for symptomatic pre-term children." @default.
• W2043935090 created "2016-06-24" @default.
• W2043935090 creator A5064277131 @default.
• W2043935090 creator A5089191522 @default.
• W2043935090 date "1992-03-01" @default.
• W2043935090 modified "2023-09-26" @default.
• W2043935090 title "Inhaled sodium cromoglycate for pre-term children with respiratory symptoms at follow-up" @default.
• W2043935090 cites W1555099863 @default.
• W2043935090 cites W1972604389 @default.
• W2043935090 cites W1984024470 @default.
• W2043935090 cites W1984462334 @default.
• W2043935090 cites W1996558852 @default.
• W2043935090 cites W2017613076 @default.
• W2043935090 cites W2040817606 @default.
• W2043935090 cites W2047788924 @default.
• W2043935090 cites W2051710922 @default.
• W2043935090 cites W2073042233 @default.
• W2043935090 cites W2090946118 @default.
• W2043935090 cites W2125197660 @default.
• W2043935090 cites W2135293612 @default.
• W2043935090 doi "https://doi.org/10.1016/s0954-6111(06)80229-5" @default.
• W2043935090 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1615179" @default.
• W2043935090 hasPublicationYear "1992" @default.
• W2043935090 type Work @default.
• W2043935090 sameAs 2043935090 @default.
• W2043935090 citedByCount "23" @default.
• W2043935090 countsByYear W20439350902012 @default.
• W2043935090 crossrefType "journal-article" @default.
• W2043935090 hasAuthorship W2043935090A5064277131 @default.
• W2043935090 hasAuthorship W2043935090A5089191522 @default.
• W2043935090 hasConcept C126322002 @default.
• W2043935090 hasConcept C142724271 @default.
• W2043935090 hasConcept C187212893 @default.
• W2043935090 hasConcept C204787440 @default.
• W2043935090 hasConcept C27081682 @default.
• W2043935090 hasConcept C2776042228 @default.
• W2043935090 hasConcept C2776178081 @default.
• W2043935090 hasConcept C2777714996 @default.
• W2043935090 hasConcept C2778376644 @default.
• W2043935090 hasConcept C2778721537 @default.
• W2043935090 hasConcept C2779234561 @default.
• W2043935090 hasConcept C2781018748 @default.
• W2043935090 hasConcept C2911192292 @default.
• W2043935090 hasConcept C42219234 @default.
• W2043935090 hasConcept C534529494 @default.
• W2043935090 hasConcept C54355233 @default.
• W2043935090 hasConcept C71924100 @default.
• W2043935090 hasConcept C75603125 @default.
• W2043935090 hasConcept C86803240 @default.
• W2043935090 hasConceptScore W2043935090C126322002 @default.
• W2043935090 hasConceptScore W2043935090C142724271 @default.
• W2043935090 hasConceptScore W2043935090C187212893 @default.
• W2043935090 hasConceptScore W2043935090C204787440 @default.
• W2043935090 hasConceptScore W2043935090C27081682 @default.
• W2043935090 hasConceptScore W2043935090C2776042228 @default.
• W2043935090 hasConceptScore W2043935090C2776178081 @default.
• W2043935090 hasConceptScore W2043935090C2777714996 @default.
• W2043935090 hasConceptScore W2043935090C2778376644 @default.
• W2043935090 hasConceptScore W2043935090C2778721537 @default.
• W2043935090 hasConceptScore W2043935090C2779234561 @default.
• W2043935090 hasConceptScore W2043935090C2781018748 @default.
• W2043935090 hasConceptScore W2043935090C2911192292 @default.
• W2043935090 hasConceptScore W2043935090C42219234 @default.
• W2043935090 hasConceptScore W2043935090C534529494 @default.
• W2043935090 hasConceptScore W2043935090C54355233 @default.
• W2043935090 hasConceptScore W2043935090C71924100 @default.
• W2043935090 hasConceptScore W2043935090C75603125 @default.
• W2043935090 hasConceptScore W2043935090C86803240 @default.
• W2043935090 hasIssue "2" @default.
• W2043935090 hasLocation W20439350901 @default.
• W2043935090 hasLocation W20439350902 @default.
• W2043935090 hasOpenAccess W2043935090 @default.
• W2043935090 hasPrimaryLocation W20439350901 @default.
• W2043935090 hasRelatedWork W2018187321 @default.
• W2043935090 hasRelatedWork W2021012065 @default.
• W2043935090 hasRelatedWork W2043935090 @default.
• W2043935090 hasRelatedWork W2048822030 @default.
• W2043935090 hasRelatedWork W2054867101 @default.
• W2043935090 hasRelatedWork W2104921121 @default.
• W2043935090 hasRelatedWork W2121366954 @default.
• W2043935090 hasRelatedWork W2410971547 @default.
• W2043935090 hasRelatedWork W2423872809 @default.
• W2043935090 hasRelatedWork W4295026881 @default.
• W2043935090 hasVolume "86" @default.
• W2043935090 isParatext "false" @default.
• W2043935090 isRetracted "false" @default.
• W2043935090 magId "2043935090" @default.
• W2043935090 workType "article" @default.